Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Rascol

Showing results (61-70 of 220) with videos related to

Pageof 22
Sort By:
Advances in Neurology|January 1, 1996
Autonomic nervous system dysfunction and adrenoceptor regulation in Parkinson's disease. Clinical and pharmacological consequencesJ L Montastruc, J M Senard, O Rascol, et al.
Clinical Neuropharmacology|January 1, 1986
Mesulergine (CU 32-085) in the treatment of Parkinson's diseaseA Rascol, J L Montastruc, O Rascol, et al.
Lancet (London, England)|April 25, 2000
Sleep attacks and Parkinson's disease treatmentJ J Ferreira, M Galitzky, J L Montastruc, et al.
The Journal of Nutrition, Health & Aging|March 24, 2006
Disease modifying trials in Alzheimer disease: methodological and statistical issuesS Andrieu, O Rascol, T Lang, et al.
European Journal of Neurology|March 22, 2008
Relationship between weight, levodopa and dyskinesia: the significance of levodopa dose per kilogram body weightJ C Sharma, I N Ross, O Rascol, et al.
Neuroscience|June 1, 1992
Alterations in the properties of hippocampal pyramidal neurons in the aged ratB Potier, O Rascol, F Jazat, et al.
Advances in Neurology|July 20, 1999
Clinical pharmacology of levodopa-induced dyskinesia in parkinsonian patientsO Rascol, C Brefel-Courbon, S Descombes, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 1, 1995
Effects of acute levodopa administration on blood pressure and heart variability in never treated parkinsoniansJ M Sénard, P Verwaerde, O Rascol, et al.
Therapie|September 12, 1998
[Central dopaminergic D1 agonists and treatment of Parkinson disease]C Soubrouillard, C Lombardo, O Rascol, et al.
Therapie|September 1, 1995
[Movement disorders induced by drugs: experience at a pharmaco-vigilance center over five years]M E Llau, J M Senard, O Rascol, et al.
Pageof 22

Showing results (61-70 of 220) with videos related to

Sort By:
Pageof 22
Advances in Neurology|January 1, 1996
Autonomic nervous system dysfunction and adrenoceptor regulation in Parkinson's disease. Clinical and pharmacological consequencesJ L Montastruc, J M Senard, O Rascol, et al.
Clinical Neuropharmacology|January 1, 1986
Mesulergine (CU 32-085) in the treatment of Parkinson's diseaseA Rascol, J L Montastruc, O Rascol, et al.
Lancet (London, England)|April 25, 2000
Sleep attacks and Parkinson's disease treatmentJ J Ferreira, M Galitzky, J L Montastruc, et al.
The Journal of Nutrition, Health & Aging|March 24, 2006
Disease modifying trials in Alzheimer disease: methodological and statistical issuesS Andrieu, O Rascol, T Lang, et al.
European Journal of Neurology|March 22, 2008
Relationship between weight, levodopa and dyskinesia: the significance of levodopa dose per kilogram body weightJ C Sharma, I N Ross, O Rascol, et al.
Neuroscience|June 1, 1992
Alterations in the properties of hippocampal pyramidal neurons in the aged ratB Potier, O Rascol, F Jazat, et al.
Advances in Neurology|July 20, 1999
Clinical pharmacology of levodopa-induced dyskinesia in parkinsonian patientsO Rascol, C Brefel-Courbon, S Descombes, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 1, 1995
Effects of acute levodopa administration on blood pressure and heart variability in never treated parkinsoniansJ M Sénard, P Verwaerde, O Rascol, et al.
Therapie|September 12, 1998
[Central dopaminergic D1 agonists and treatment of Parkinson disease]C Soubrouillard, C Lombardo, O Rascol, et al.
Therapie|September 1, 1995
[Movement disorders induced by drugs: experience at a pharmaco-vigilance center over five years]M E Llau, J M Senard, O Rascol, et al.
Pageof 22